Department of Psychiatry

Penn Behavioral Health

Seminars

Mondays at 3:00 p.m. 
3900 Chestnut Street

 

Fall 2016

September 19
Salina Samion, PhD
CNB Psychological Servies Unit
Central Narcotics Bureau, Singapore
Substance Use Disorders and Their Treatment in Singapore

September 26, 2016
Kevin Lynch, PhD
University of Pennsylvania, Department of Psychiatry
Analyses of heavy drinking in a topiramate study

October 3, 2016
Zhenhao Shi, PhD
University of Pennsylvania, Department of Psychiatry
Extended-release naltrexone specifically blunts the mesocorticolimbic response to opioid-related images in opioid-dependent patients

October 10, 2016
Douglas Wiebe, PhD
University of Pennsylvania, Department of Clinical Epidemiology and Biostatistics 
Ignition Interlock Laws and Alcohol-Involved Crash Deaths

October 17, 2016
Dan Polsky, PhD
University of Pennsylvania, Department of Health Care Management
Cost-Effectiveness of Depot Naltrexone to Prevent Relapse Among Criminal-Justice-Involved Persons with a History of Opioid Use Disorder

October 24, 2016
Kenzie L. Preston, PhD
NIH National Institute on Drug Abuse, Clinical Pharmacology and Therapeutics Research Branch
Substance Abuse Research with Mobile Technology

October 31, 2016
Charles O’Brien, MD
University of Pennsylvania, Department of Psychiatry
Relapse prevention using depot naltrexone for parolees

November 7, 2016
Christos Davatzikos, PhD
University of Pennsylvania, Department of Radiology
Deriving personalized neuroimaging signatures using machine learning in the presence of heterogeneity: applications to brain aging, Alzheimer's Disease, and schizophrenia

November 14, 2016
Mohit Prajapati, MSc(Eng), MBA and Sam Frons
http://addicaid.com
Addicaid: An application for personalized addiction treatment

November 21, 2016
Daniel Weintraub, MD
University of Pennsylvania, Department of Psychiatry
Impulse Control Disorders in Parkinson's Disease

November 28, 2016
Falk Lohoff, MD
National Institute on Alcohol Abuse and Alcoholism, Chief of Section on Clinical Genomics and Experimental Therapeutics
TBA

December 5, 2016
Ilana Pinsky, PhD
The National Center on Addiction and Substance Abuse
`Cracolandia`, an open drug scene in Brazil: treatment opportunities and challenges

December 12, 2016
Robert Mach, PhD
University of Pennsylvania, Department of Radiology
TBA

December 19, 2016
Tracy Bale, PhD
University of Pennsylvania, Neuroscience Center SOVM
TBA
Back to Top

Spring 2017 (more to be announced)

January 23, 2017
Anne M. Teitelman, PhD, FNP-BC, FAANP, FAAN
University of Pennsylvania, School of Nursing
TBA

January 30, 2017
Deborah S. Hasin, PhD
Columbia University, Department of Psychiatry & Epidemiology
TBA

February 6, 2017
Cécile Denis, PhD
University of Pennsylvania, Department of Psychiatry
TBA

February 13, 2017
Peggy Compton, RN, PhD, FAAN
Georgetown University, School of Nursing and Health Studies
TBA

March 13, 2017
Anna Rose Childress, PhD
University of Pennsylvania, Department of Psychiatry
TBA

March 20, 2017
Adam Bisaga, MD
Columbia University Medical Center, Department of Psychiatry
TBA

April 3, 2017
Marisa Silveri, PhD
Harvard Medical School, Department of Psychiatry
TBA

April 17, 2017
Michael Lowe, PhD and Samantha Winter, PhD Candidate
Drexel University, Department of Psychology
Weight Gain, Weight Loss and Body Mass: Is the Noise a Signal?
Back to Top

Past Seminars
 

Spring 2016

January 11
Francis Levin, MD
Columbia University Medical Center, Department of Psychiatry
ADHD in Substance Abuse

January 25
Martin Cheatle, PhD
University of Pennsylvania, Department of Psychiatry 
Phenotypic and genotypic characteristics of opioid use disorder in patients with chronic non cancer pain

February 1
Charles Branas, PhD
University of Pennsylvania, Department of Biostatistics and Epidemiology 
Changing Places to Improve Health 

February 8
Jennifer Prah Ruger, PhD, MSc, MA, MSL
University of Pennsylvania, Department of Medical Ethics & Health Policy 
Micro costing: studies, systematic review and checklist development

February 29
Walter Kraft, MD, MS, FACP
Thomas Jefferson University, Clinical Pharmacology
Novel Therapies for Neonatal Abstinence Syndrome

March 7
Rick C. Crist, III, PhD
University of Pennsylvania, Department of Psychiatry
The Pharmacogenetics of Opioid Dependence Treatment

March 14
Dennis Hand, PhD 
Thomas Jefferson University
Strategies for Preventing Unintended Pregnancies Among Women in Substance Abuse Treatment

March 21
Raye Litten, PhD 
National Institutes of Health, NIAAA 
A Vision for the Next Decade to Advance Medications Development to Treat Alcohol Use Disorder

March 28
J. Cobb Scott, PhD
University of Pennsylvania, Department of Neuropsychiatry
Cannabis and Cognitive Functioning - Findings from the Philadelphia Neurodevelopmental Cohort

April 4
John Cacciola, PhD
University of Pennsylvania, Department of Psychiatry
Performance Monitoring in Addiction Treatment

April 11
Lyle Ungar, PhD
University of Pennsylvania, Computer and Information Science 
Social Media Language Analysis for Health Behaviors

April 18
Dennis Durbin, MD, MSCE 
University of Pennsylvania/CHOP, Department of Pediatrics
Being Intentional about Work/Life Integration

May 2
John Farrar, MD 
University of Pennsylvania, Department of Epidemiology and Biostatistics
Brain Imaging in Pain and Addiction

May 9
Marlow Kee 
University of Pennsylvania, Executive Director of the Comptroller 
A comptroller’s-eye view of funds flow in the Perelman School of Medicine and the University of Pennsylvania

May 16
Marja Evenden, MD 
University of Pennsylvania, Department of Psychiatry
On GABA-A Receptor Ligands in Clinical Psychiatry

May 23
Robin Stevens, PhD, MPH 
University of Pennsylvania, School of Nursing
Social Media and Other Drugs: Sex and substance use among inner city youth. 
June 20
Bethany Raiff, PhD, BCBA-D
Rowan University, Department of Psychology 
Technology-based interventions for increasing healthy behavior 
Back to Top

Fall 2015

September 14
Diane Abatemarco, PhD, MSW
Research in Mindfulness Based Programs with Women Treated for Opioid Addiction Post-Partum & with Pregnant Women at Risk for Preterm Birth

September 21
Subhajit Chakravorty, MD
Alcohol and Sleep Continuity Distrubance: Newer Insights

October 5
Steven E. Lankenau, PhD
Health Conditions and Patterns of Marijuana Use among Young Adult Medical Marijuana Patients in Los Angeles

October 12
Teresea Franklin, PhD
Influence of Sex on Neural Processing Of Subliminal Cannabis Cues In Cannabis Use Disorder (CUD): Implications for Treatment Strategies

October 19
Craig A. Umscheid, MD, MSCE
Intro to Systematic Reviews and Meta-analyses

October 26
Ulf  Muller, MD
A controlled funded study of DBS for alcoholism in Germany

November 2
David Thomas, MD
NIDA Current and Future Initiatives in Pain and Addiction

November 9
Peg Calder
FAR: Why, How, and What

November 16
Andrew Strasser, PhD
Applying Human Laboratory Research to FDA Regulation of Tobacco Products

November 23
Mehmet Sofouglu, MD, PhD
Role of Progesterone in Additive Disorders: Human Laboratory and Clinical Trial Findings

November 30
Deni Carise, PhD
Developing De Novo Substance Abuse Treatment Programs – Zoning, Stigma and other challenges

December 14
Hengyi Rao, PhD
Smoking to be normal: A multimodal neuroimaging study of nicotine abstinence

December 21
Janet Audrain, PhD
Using Behavioral Economics to Understand Smoking Uptake and Persistence
Back to Top

Spring 2015

February 2
Sara Ward, PhD
Cocaine, cannabinoids, and inflammation

February 9
David Metzger, PhD
Drug Treatment as HIV Prevention in Asia: from Harm reduction to Addiction Treatment

February 23
Hans Rollema, PhD
Varenicline (Chantix) a decade later: an update on pharmacology, efficacy, adverse events and other indication

March 2
Andrea King, PhD
If you build it, they will come: a longitudinal framework for alcohol challenge research in at-risk drinkers 
March 9
Julie Blendy, PhD
Stress, alcohol and the social mouse: Functional characterization of Oprm1 SNP

March 16
Robert Gross, MD, MSCE
Impact of Hazardous Ethanol Consumption on HIV Outcomes in Botswana

March 23
Emily Falk, PhD
Neural predictors of health behavior change

March 30
Alyse Thomas, PhD
Stress promotes alcohol consumption through excitatory GABA transmission in the VTA

April 6
Irwin Lucki, PhD
Repurposing Buprenorphine for Depression and Anxiety Disorders

April 27
Victor Hesselbrock, PhD
TBA

May 4
Erika Perez, PhD and Duncan Van Nest, BS
GluK1-containing Kainate Receptor Antagonists as Potential Pharmacotherapies for Alcohol and Cocaine Dependence

May 11
Paul Lanken, MD
Efficacy of an Online Educational Module plus Debriefing to Improve Attitudes and Communication Skills Related to Patients with Substance Use
Back to Top

Fall 2014

September 8
Dr. Robert Schnoll, PhD 
Improving Treatments for Nicotine Dependence

September 15
Dr. Yukiko Washio, PhD
Addressing Maternal Health Issues with a Comprehensive Approach

September 22
Dr. Brenda Curtis, PhD 
Using Marketing Techniques to Recruit and Retain Research Participants

September 29
Dr. Joseph Schacht, PhD 
Identification of Neural Targets for Pharmacological Treatment in Alcohol Use Disorders

October 6
Dr. Amy Hart, MD
Investigating the Genetic Influences on Substance Use Disorders Using a  Genome-Wide Approach

October 13
Dr. Reagan Wetherill, PhD 
TBA

October 20
Dr. Kimberly Kirby, PhD 
Progress Report from the Parents' Translational Research Center
October 27
Dr. John Dani, PhD
Dopaminergic Mechanisms Contributing to the Nicotine Addiction Process

November 3
Dr. David Festinger, PhD 
Delivering HIV Risk Reduction Services in Drug Court

November 10
Dr. Neil Epperson, MD 
What? You Give Progesterone to Men? The Role of Neurosteroids in Nicotine Dependence

November 17
Dr. Rebecca Ashare, PhD
From brain to behavior: The role of APOE ε4 genotype, a susceptibility allele for Alzheimer’s disease, in nicotine dependence

November 24
Dr. Kenneth Silverman, PhD 
Incentives & Health: The Application of Operant Conditioning in Health Promotion

December 1
Jeremy Mennis, PhD
Addiction and the Environment: Why Place Matters to Substance Abuse and Treatment

December 15
Dr. Kyle Kampman, MD
An Update on Topiramate for Cocaine Dependence

December 22
Dr. Heath Schmidt, PhD 
TBA


Back to Top